A61P 27 - Drugs for disorders of the senses

Patents for A61P 27 - Drugs for disorders of the senses (53,017)
10/1997
10/09/1997	WO1997036891A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036890A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036889A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036888A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036886A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036879A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036877A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036876A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036871A1 6-phenylpyridyl-2-amine derivatives
10/09/1997	WO1997036862A1 META-SUBSTITUTED PHENYLENE DERIVATIVES AND THEIR USE AS ALPHAvBETA3 INTEGRIN ANTAGONISTS OR INHIBITORS
10/09/1997	WO1997036859A1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists
10/09/1997	WO1997036605A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036593A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036592A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036591A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036585A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036584A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036583A1 Inhibitors of farnesyl-protein transferase
10/09/1997	WO1997036547A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins
10/09/1997	CA2250937A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2250936A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2250843A1 Heterocyclic compounds and their preparation and use
10/09/1997	CA2250698A1 Para-substituted phenylpropanoic acid derivatives as integrin antagonists
10/09/1997	CA2250587A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2250464A1 Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors
10/09/1997	CA2250460A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2250353A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2250204A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2250203A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2250192A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2250190A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2250143A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2249665A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2249650A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2249645A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2249641A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2249617A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2249615A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2249607A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2249605A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2249604A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2249599A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2249559A1 Inhibitors of farnesyl-protein transferase
10/09/1997	CA2248856A1 Improved tissue destruction in cryosurgery by use of thermal hysteresis proteins
10/08/1997	EP0799219A2 Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibitors and non-steroidal anti-inflammatory products
10/08/1997	EP0799198A1 Anti-inflammatory compounds
10/08/1997	EP0799188A2 Amides of mono and bicarboxylic acids with amino acids or glycosamines, selectively active on the cannabinoid peripheral receptor
10/08/1997	EP0799044A2 Topical ophthalmic formulations containing doxepin derivatives for treating allergic eye diseases
10/08/1997	EP0799037A1 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine
10/08/1997	EP0799033A1 Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor
10/08/1997	EP0655062B1 Morpholino/thiomorpholino-terminated alkylamino ethynyl alanine amino diol compounds as renin inhibitors
10/08/1997	EP0482089B1 Method of treating autoimmune uveoretinitis in human
10/07/1997	US5675008 Excitatory amino acid receptor antagonists
10/07/1997	US5674910 7-(5-substituted cyclopentyl) and (5-substituted cyclopentenyl) heptyl alcohols, heptylamines and heptanoic acid amides, and method of lowering intraocular pressure in the eye of a mammal by administration of these novel compounds
10/07/1997	US5674888 Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
10/07/1997	US5674866 Antiallergic imidazoazepines
10/02/1997	WO1997035864A1 Phosphoramidates and phosphinic amides, their use to modulate the activity of endothelin
10/02/1997	WO1997035852A1 Thiazolidine-4-carboxylic acid derivatives as cytoprotective agents
10/02/1997	WO1997035604A1 Pharmaceutical compositions of botulinum toxin or botulinum neurotoxin and methods of preparation
10/02/1997	WO1997035591A2 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds
10/02/1997	WO1997035567A1 Pla2 inhibitors of angiogenesis
10/01/1997	EP0798375A2 Human lens epithelial cell line
10/01/1997	EP0797988A2 Anti-angiogenic compositions and methods of use
10/01/1997	EP0797442A1 Treatment of optic neuritis
10/01/1997	CN1161000A Topical ophthalmic formulations containing Doxepin derivatives for treating allergic eye diseases
10/01/1997	CN1160999A Non-irritation, non-sensitizing non-ototoxic otic antibacterial compositions
09/1997
09/30/1997	US5672709 Heterocyclic compounds and their preparation and use
09/30/1997	US5672602 Substituted piperazine derivatives
09/30/1997	US5672355 Injection of liquid silicone/fluorosilicone copolymer oil for repairing detached retina or drug delivery during eye surgery
09/30/1997	CA2091686C Crystalline modification of 2-dimethylaminoethyl-n-butylaminobenzoate hydrochloride, method for production thereof and pharmaceutical preparation for anesthesia of eyes, based thereon
09/29/1997	CA2201216A1 Human lens epithelial cell line
09/25/1997	WO1997034899A1 Heterocyclic compounds and their preparation and use
09/25/1997	WO1997034885A1 Benzopyran derivatives having leukotriene-antagonistic action
09/25/1997	WO1997034586A2 Device and method for treating ophthalmic diseases
09/25/1997	WO1997030704A3 Use of carbonic anhydrase inhibitors for treating macular edema
09/25/1997	WO1997017446A3 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
09/25/1997	CA2248153A1 Heterocyclic compounds and their preparation and use
09/24/1997	EP0796855A1 Inhibitors of bone resorption and vitronectin receptor antagonists
09/24/1997	EP0796330A1 Rantes peptide and fragments and compositions comprising it for treatment of inflammation
09/24/1997	EP0796322A1 Production and use of human and plant methyltransferases
09/24/1997	EP0796270A2 Peptide compounds for prevention and/or treatment of no-mediated diseases
09/24/1997	EP0696280B1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists
09/24/1997	EP0556296B1 2-decarboxyl-2-aminoalkyl-prostaglandins as ocular hypotensives
09/24/1997	CN1160398A Compositions and methods for treating mast-cell inflammatory condition
09/24/1997	CN1160347A Use of indole drivs. for treatment of dermatological disorders peripheral neuropathied, arthritis, headache, orofacial pain, allergic or chronic obstructive airways desease, glaucoma and ocular.
09/24/1997	CN1160045A Matrix metalloprotease inhibitors
09/24/1997	CN1159949A Use of peptide compounds and pharmaceutically acceptable salts thereof for manufacturing medicament for treating diseases
09/23/1997	US5670516 Excitatory amino acid receptor antagonists
09/23/1997	US5670505 Tachykikin antagonist for respiratory diseases, ophthalmic diseases and antiinflammatory agents
09/23/1997	US5670504 2,6-diaryl pyridazinones with immunosuppressant activity
09/23/1997	US5670493 Angiogenesis inhibitors
09/23/1997	US5670482 Neuropeptide Y antagonists
09/20/1997	CA2199923A1 Novel inhibitors of bone reabsorption and antagonists of vitronectin receptors
09/18/1997	WO1997033887A1 Spirocycle integrin inhibitors
09/18/1997	WO1997033881A1 Bicyclic-aromatic compounds
09/18/1997	WO1997033619A1 Improved vision through photodynamic therapy of the eye
09/18/1997	WO1997033616A1 Methods for treatment of allergic diseases with ige
09/18/1997	CA2249733A1 Spirocycle integrin inhibitors
09/18/1997	CA2246427A1 Methods for treatment of allergic diseases with ige
09/17/1997	EP0795333A2 TGF-beta regulating substance for treatment of myopia or hyperopia

1 ... 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 ... 531